Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 24. Februar 2021
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 11841  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 236820  
   
Ovarian Cancer

Arora T, Mullangi S, Lekkala MR, Arora T, Mullangi S, Lekkala MR.
PMID: 33620837 [PubMed]


The role of altered long noncoding RNAs in overall survival of ovarian cancer: A systematic review and meta-analysis.
Pathol Res Pract
Seyed Hosseini E, Alizadeh Zarei M, Haddad Kashani H, Milajerdi A, Zare Dehghanani Z, Hassani Bafrani H, Nikzad H.
PMID: 33621920 [PubMed - as supplied by publisher]


Molecular mechanism study of BPAF-induced proliferation of ERα-negative SKBR-3 human breast cancer cells in vitro/in vivo.
Sci Total Environ
Lei B, Xu L, Tang Q, Sun S, Yu M, Huang Y.
PMID: 33621883 [PubMed - as supplied by publisher]


Examination of incidence, mortality and disability-adjusted life years and risk factors of breast cancer in 49 Asian countries, 1990-2019: estimates from Global Burden of Disease Study 2019.
Jpn J Clin Oncol
Sharma R.
PMID: 33621341 [PubMed - as supplied by publisher]


Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.
PLoS One
Wanandi SI, Limanto A, Yunita E, Syahrani RA, Louisa M, Wibowo AE, Arumsari S.
PMID: 33621270 [PubMed - as supplied by publisher]


Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
Cancer
Mukama T, Kharazmi E, Sundquist K, Sundquist J, Fallah M.
PMID: 33620751 [PubMed - as supplied by publisher]


Survival of women diagnosed with breast cancer and who have survived a previous cancer.
Breast Cancer Res Treat
Pruitt SL, Zhu H, Heitjan DF, Rahimi A, Maddineni B, Tavakkoli A, Halm EA, Gerber DE, Xiong D, Murphy CC.
PMID: 33620590 [PubMed - as supplied by publisher]


Association of Obesity with Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis.
J Natl Cancer Inst
Lohmann AE, Soldera SV, Pimentel I, Ribnikar D, Ennis M, Amir E, Goodwin PJ.
PMID: 33620467 [PubMed - as supplied by publisher]


Breast Cancer Screening with Abbreviated Breast MRI: 3-year Outcome Analysis.
Radiology
Kwon MR, Choi JS, Won H, Ko EY, Ko ES, Park KW, Han BK.
PMID: 33620293 [PubMed - as supplied by publisher]


Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study.
Jpn J Clin Oncol
Shao Z, Tseng LM, Huang CS, Pang D, Yang Y, Li W, Liao N, Geng C, Zhang Q, Xu B, Liu D, Kwong A, et al (continued in the appendix)..
PMID: 33619550 [PubMed - as supplied by publisher]


Hysterectomy and risk of breast, colorectal, thyroid and kidney cancer - an Australian data linkage study.
Cancer Epidemiol Biomarkers Prev
Wilson LF, Tuesley KM, Webb PM, Dixon-Suen SC, Stewart LM, Jordan SJ.
PMID: 33619026 [PubMed - as supplied by publisher]


Iron intake with the risk of breast cancer among Chinese women: a case-control study.
Public Health Nutr
Liu KY, Feng XL, Mo XF, Lin FY, Zhang X, Huang CY, Abulimiti A, Li L, Zhang CX.
PMID: 33618790 [PubMed - as supplied by publisher]


High-intensity interval training in breast cancer survivors: a systematic review.
BMC Cancer
Tsuji K, Matsuoka YJ, Ochi E.
PMID: 33618699 [PubMed - in process]


Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer.
BMC Cancer
Berger K, Rhost S, Rafnsdóttir S, Hughes É, Magnusson Y, Ekholm M, Stål O, Rydén L, Landberg G.
PMID: 33618683 [PubMed - in process]


Two-year toxicity of simultaneous integrated boost in hypofractionated prone breast cancer irradiation: comparison with sequential boost in a randomized trial.
Radiother Oncol
Van Hulle H, Desaunois E, Vakaet V, Paelinck L, Schoepen M, Post G, Van Greveling A, Speleers B, Mareel M, De Neve W, Monten C, Deseyne P, Veldeman L.
PMID: 33617910 [PubMed - as supplied by publisher]


Survival Outcomes of Breast Cancer in Sudanese Women: A Hospital-Based Study.
JCO Glob Oncol
Muddather HF, Elhassan MMA, Faggad A.
PMID: 33617296 [PubMed - in process]


DTX3 copy number increase in breast cancer: a study of associations to molecular subtype, proliferation and prognosis.
Breast Cancer Res Treat
Valla M, Opdahl S, Ytterhus B, Bofin AM.
PMID: 33616774 [PubMed - as supplied by publisher]


Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study.
Breast Cancer Res Treat
Tang M, Schaffer AL, Kiely BE, Daniels B, Lee CK, Simes RJ, Pearson SA.
PMID: 33616773 [PubMed - as supplied by publisher]


Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator.
Ann Surg Oncol
Jonczyk MM, Fisher CS, Babbitt R, Paulus JK, Freund KM, Czerniecki B, Margenthaler JA, Losken A, Chatterjee A.
PMID: 33616770 [PubMed - as supplied by publisher]


The Clinical Application Value of RDW, CA153, and MPV in Breast Cancer.
Clin Lab
Lu F, Pan S, Qi Y, Li X, Wang J.
PMID: 33616344 [PubMed - in process]


   
   Artikel 1 - 20 / 236820    Seite 1 von 11841  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1